deaths (OS)

es-BC - TNBC - NA - all population breast cancer - triple negative es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) es-BC - TNBC - NA - all population

versus placebo
olaparib vs. placebo 1 0.68 [0.47; 0.98], 1 RCT, I2=0% conclusive
unassessable degree of certainty